According to Takara Bio's latest financial reports the company's current revenue (TTM ) is โน25.48 Billion. In 2023 the company made a revenue of โน28.29 Billion a decrease over the revenue in the year 2022 that were of โน51.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โน24.58 B | -13.09% |
2023 | โน28.29 B | -45.12% |
2022 | โน51.54 B | 24.53% |
2021 | โน41.39 B | 51.36% |
2020 | โน27.34 B | 21.28% |
2019 | โน22.54 B | -0.14% |
2018 | โน22.58 B | 26.55% |
2017 | โน17.84 B | -4% |
2016 | โน18.58 B | 14.8% |
2015 | โน16.19 B | 10.19% |
2014 | โน14.69 B | 2.95% |
2013 | โน14.27 B | 6.21% |
2012 | โน13.43 B | 5.39% |
2011 | โน12.75 B | 31.51% |
2010 | โน9.69 B | 3.57% |
2009 | โน9.36 B |